Cochrane · systematic review · CD009202
Propofol versus thiopental sodium for the treatment of refractory status epilepticus
Prabhakar, H, Kalaivani, M · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
EpilepsyAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
3
current version
GRADE rated
2
No studies
1
Included studies
NR
No studies 1 · 33.3%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 66.7%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Propofol compared to Thiopental sodium for the treatment of refractory status epilepticus
Population: patients with the treatment of refractory status epilepticus
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Total control of seizures Propofol vs Thiopental sodium | RR 1.5 [0.4, 5.61] | 1 study · 21 participants | Low Downgraded: risk of bias, imprecision |
In‐hospital mortality Propofol vs Thiopental sodium | RR 1.5 [0.19, 11.93] | 1 study · 21 participants | Low Downgraded: risk of bias, imprecision |
Length of intensive care unit (ICU) stay Propofol vs Thiopental sodium | no estimate extracted | NR | No studies |